We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Novavax RSV F Vaccine Fails Phase 3 Trial

News   Sep 20, 2016

 
Novavax RSV F Vaccine Fails Phase 3 Trial
 
 
 

RELATED ARTICLES

British Columbia’s HPV Vaccination Program Reduces Cervical Pre-cancer Rates by > 50%

News

British Columbia’s school-based human papillomavirus (HPV) immunization program is reducing rates of cervical pre-cancer in B.C. women, according to a new study.

READ MORE

Revival of 50,000-Year-Old Gene Reveals How Deadliest Malaria Parasite Jumped From Gorillas to Humans

News

In a study published today in PLOS Biology, researchers from the Wellcome Sanger Institute and the University of Montpellier have reconstructed a ~50,000-year-old gene sequence acquired by the ancestor of Plasmodium falciparum. The acquisition of the gene sequence enabled the parasite to infect human red blood cells.

READ MORE

Vaccine Against RSV in Sight?

News

Scientists are one step closer to finding a successful vaccine for the common and sometimes deadly RSV, a leading cause of pediatric hospitalizations.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE